You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TAK-700

Showing 1 - 25 of 586
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer Trial in United States (Orteronel)

Completed
Has Results
  • Metastatic Breast Cancer
  • New Haven, Connecticut
  • +9 more
Jun 8, 2022

Post Menopausal, Hormone Receptor Positive Breast Cancer Trial in Madison (TAK700)

Completed
  • Post Menopausal, Hormone Receptor Positive Breast Cancer
  • Madison, Wisconsin
    University of Wisconsin
Nov 14, 2019

Prostatic Tumors, Prostate Cancer Trial in Madison (drug, radiation, procedure)

Terminated
Has Results
  • Prostatic Neoplasms
  • Prostate Cancer
  • TAK-700
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Nov 19, 2019

Takayasu Arteritis Trial in Japan (Ustekinumab, Placebo, Glucorticoid Taper Regimen)

Recruiting
  • Takayasu Arteritis
  • Bunkyo-Ku, Japan
  • +28 more
Aug 16, 2022

Prostate Cancer Trial in United States (TAK-700, Bicalutamide)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Birmingham, Alabama
  • +559 more
Dec 5, 2022

Prostate Cancer Trial in Anchorage (TAK-700, Docetaxel, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • TAK-700
  • +2 more
  • Anchorage, Alaska
    Alaska Clinical Research Center, LLC
Jul 9, 2019

Takayasu Arteritis (TAK) Trial in Worldwide (Upadacitinib, Placebo for Upadacitinib, Prednisolone)

Recruiting
  • Takayasu Arteritis (TAK)
  • Salvador, Bahia, Brazil
  • +44 more
Aug 22, 2022

Diabetic Gastroparesis, Idiopathic Gastroparesis Trial in Worldwide (TAK-906 Maleate, TAK-906 Maleate Placebo)

Completed
Has Results
  • Diabetic Gastroparesis
  • Idiopathic Gastroparesis
  • TAK-906 Maleate
  • Placebo
  • Dothan, Alabama
  • +108 more
Oct 24, 2022

Primary Immunodeficiency Diseases (PID) Trial (TAK-881)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • (no location specified)
Oct 4, 2023

NSCLC Trial in Worldwide (TAK-788)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Birmingham, Alabama
  • +56 more
Jan 23, 2023

Narcolepsy Type 1, Narcolepsy Type 2 Trial (TAK-861)

Not yet recruiting
  • Narcolepsy Type 1
  • Narcolepsy Type 2
  • (no location specified)
Mar 31, 2023

Renal Impairment, Healthy Volunteers Trial in Miami, Orlando, Chicago (TAK-279)

Not yet recruiting
  • Renal Impairment
  • Healthy Volunteers
  • Miami, Florida
  • +2 more
Aug 8, 2023

Hepatic Impairment, Healthy Volunteers Trial in Miami, Orlando, San Antonio (TAK-279)

Not yet recruiting
  • Hepatic Impairment
  • Healthy Volunteers
  • Miami, Florida
  • +3 more
Jul 28, 2023

Dravet Syndrome (DS) Trial in Worldwide (Soticlestat, Placebo)

Recruiting
  • Dravet Syndrome (DS)
  • Phoenix, Arizona
  • +95 more
Jan 10, 2023

Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis Trial in United States (ANK-700, Placebo)

Recruiting
  • Multiple Sclerosis (MS)
  • Relapsing Remitting Multiple Sclerosis
  • Cullman, Alabama
  • +14 more
Dec 13, 2022

Tumors, Lymphoma, Hematologic Tumors Trial in Ukraine, United States (TAK-981)

Recruiting
  • Neoplasms
  • +2 more
  • La Jolla, California
  • +15 more
Dec 7, 2022

Healthy Volunteers Trial in Tempe (TAK-279, Erythromycin, Phenytoin)

Not yet recruiting
  • Healthy Volunteers
  • Tempe, Arizona
    Celerion - Tempe, AZ Site
Aug 9, 2023

Narcolepsy Type 1 (NT 1) Trial in Worldwide (TAK-994, Placebo)

Terminated
  • Narcolepsy Type 1 (NT 1)
  • Alabaster, Alabama
  • +69 more
Oct 5, 2022

Prostate Cancer Trial in Switzerland (Orteronel, Placebo)

Completed
  • Prostate Cancer
  • Aarau, Switzerland
  • +14 more
May 13, 2019

Healthy Volunteers Trial in Shanghai (TAK-279, Placebo)

Not yet recruiting
  • Healthy Volunteers
  • Shanghai, China
    Huashan Hospital Fudan University
Oct 27, 2023

Plaque Psoriasis Trial (TAK-279, Placebo, Apremilast)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Oct 25, 2023

Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2) Trial in Worldwide (TAK-994, Placebo)

Terminated
  • Narcolepsy Type 1 (NT1)
  • Narcolepsy Type 2 (NT2)
  • Alabaster, Alabama
  • +77 more
Oct 5, 2022

Plaque Psoriasis Trial (TAK-279, Placebo, Apremilast)

Not yet recruiting
  • Plaque Psoriasis
  • (no location specified)
Oct 12, 2023

Pancreatic Cancer, Hepatocellular Cancer, Squamous Cell Cancer (SCC) Trial in United States (TAK-500, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +9 more
  • Duarte, California
  • +6 more
Jan 17, 2023

Healthy Volunteers Trial in Glendale (TAK-951 Placebo, TAK-951)

Completed
  • Healthy Volunteers
  • Glendale, California
    California Clinical Trials Medical Group
Oct 11, 2022